enough bite bark
first guidanc soft focu remain dental
wrap event somewhat challeng highlight
weaker na dental sale least somewhat attribut softer market
time compani still grew dental consum outpac view
recent overal market growth anim health spin/creat
specif metric take even greater import eye investor
soft like scrutin close addit underli guidanc
came expect includ extrem wide rang estim
within consensu ultim expect move
forward post-anim world think compani still well posit
take share dental/med well layer bolt-on acquisit given
somewhat premium valuat rel growth rate see upside/downsid
potenti balanc reiter neutral rate lower po
maintain ev/ebitda multipl
reduc ep operational/non-oper chang
reduc ep estim modestli
ep chang reflect lower revenu estim slightli
higher opex assumpt lower buy-back assumpt lower interest expens
well
upcom event catalyst
follow anim health spin releas guidanc near-term focu hisc
upcom industri confer light shine new technolog
introduct end market demand includ chicago midwint confer
begin biannual id confer germani mid-march also
look addit intra-quart updat increment growth prioriti
addit given compani focu post-spin
net dbt
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
one world largest distributor
dental medic product also provid
solut broad rang financi servic
primarili fragment custom base
compani headquart melvil new york
oper countri
remain market leader experienc
growth headwind still trade premium
valuat peer group compani
share gainer across key market dental
busi also see acceler contribut
equip side transit
trend still remain difficult predict na
medic see moder growth due multi-
soft dental consum november/decemb time
believ tax could neg impact year-end sale
expect see acceler technolog sale due sale
receiv cash free tax proce distribut end
close use pay corpor debt
expect continu pursu strateg plan
adjust ep guidanc assum growth continu oper
expect ep growth low singl digit first quarter year
increas cours year
expect grow market share percentag point market
gross oper margin
recogn continu oper competit market
consolid continu differ rate dental
guidanc strand cost tsa agreement help
cash infus impact three
cash infus month impact
interest rate one temporari credit line place
anticip receiv payment
assum interest expens would includ increas interest
expens relat higher
still expect currenc translat neg impact result
think margin year
long-term goal get back margin expans
believ get time
oper margin expans assum sale shift
acquir higher margin product could help
dental consum earli weak late
special sale stronger core gp sale
soft continu januari saw nice pick-up februari
implant busi grew rang
littl optimist pick-up
profit one specialti busi
significantli higher distribut busi
caus dental pressur november/decemb
see larg corpor account grow faster
see anyth region geograph
price object base stand-alone ev/ebitda
remain busi follow spin-off merger anim health
busi lower end compani histor trade rang account
less visibl growth/margin opportun
upsid risk po stronger expect dental consumable/equip sale
either new relationship sirona share win cost ration downsid
risk uncertainti creat ftc complaint alleg price conspiraci
henri schein/patterson companies/benco dental suppli wors expect
share gain sirona-rel revenu new competit amazon creat
signific growth margin pressur segment
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
